Grupo de Melanoma

Inicio | Investigación e innovación | Programas Científicos | Programa de Oncología Molecular | Grupo de Melanoma


  • Nuria Gago
  • David Olmeda

Becarios Post-doctorales

  • Susana Frago
  • María Magdalena Leal
  • Adriana Sanna

Becarios Pre-Doctorales

  • Xavier Catena
  • Marta Contreras
  • Naiara Juan
  • Sergio Oterino
  • Cristina Tejedo

Técnicos de Laboratorio

  • Tonantzin Guadalupe Calvo
  • Cynthia Mucientes
  • Mireia Vallespinós

Melanomas are inherently aggressive cancers for which basic and translational research have significantly improved patient prognosis. Nevertheless, clinical responses are still incomplete. The long-term goals of our Group are to identify new progression biomarkers and therapeutic agents. We are particularly interested in mechanisms of cellular stress that, being selectively deregulated in melanoma, define lineage-specific vulnerabilities (publications in Nature, Cancer Cell, Nature Cell Biology, Nature Communications, among others). Our laboratory has also generated the firstin- class lymphoreporter mice for non-invasive imaging of pre-metastatic niches in melanoma (Nature). These systems have led to the validation of nanoparticle-based treatments that are currently being tested in clinical trials. Our ultimate objective is to improve the management of patients with otherwise refractory metastatic melanomas.